Company Page
HERA
Founders
HERA is a B2B manufacturing intelligence platform that automates the review of 2D engineering drawings before parts go to the shop floor. By checking dimensions, tolerances, and GD&T callouts against ASME and ISO standards in minutes rather than days, HERA eliminates costly errors and bottlenecks for engineer-to-order manufacturers in aerospace, medical devices, semiconductor, and pressure vessel industries. Backed by Y Combinator (Summer 2026), HERA is co-founded by Meera Patel and Noelle So and is already live in production plants.
Company Founded in 2026
SaaSArticles about HERA
AptaDir raises $1.6M pre-seed for RNA cancer therapeutics
Healthtech & BiotechSep 29, 2026
Amyl Therapeutics raises $9.4M for multi-target Alzheimer's drug
Healthtech & BiotechSep 2, 2026
AI Drawing Review Tools Target Manufacturing's Costly Quality Gaps
SaaSAug 9, 2026
Brano Therapeutics Raises $6.8M Seed for Heart Failure Therapies
Healthtech & BiotechJul 25, 2026
Telum Therapeutics Raises €18M Series A for AI-Driven Antibiotics
Healthtech & BiotechJul 2, 2026
TRIMTECH Raises $47M Seed Led by J&J for Neurodegenerative Drugs
Healthtech & BiotechJun 24, 2026
Peel Therapeutics Closes Series A for Nature-Inspired Cancer Drugs
Healthtech & BiotechJun 14, 2026
Immuneel Raises $12M to Make Cancer Therapy 90% More Affordable
Healthtech & BiotechJun 8, 2026
Tavo Biotherapeutics Raises $17M for First Disease-Modifying Glaucoma Drug
Healthtech & BiotechJun 3, 2026
AstriVax's €30M Seed Targets HPV Cancer With Novel Platform
Healthtech & BiotechJun 3, 2026